Inhibition of ABC-transporter(s)' function in non-small cell lung cancer cells under platinum drugs effect

Antibiotiki i Khimioterapiya

Volumn 48, Issue 10, 2003, Pages 11-15

  Bogush, T A ^a   Konukhova, A V ^a   Ravcheeva, A B ^a   Zabotina, T N ^a   Kadagidze, Z G ^a   Bogush, E A ^a   Komov, D V ^a   Polotskiy, B E ^a   Laktionov, K K ^a   Davydov, M I ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

ABC transporters; Doxorubicin; MDR phenotype; Non small cell lung cancer; Platinum drugs

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ENZYME INHIBITOR; GENISTEIN; GLYCOPROTEIN P; VERAPAMIL;

ARTICLE; BIOPSY; CELL NUCLEUS; CYTOPLASM; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; MULTIDRUG RESISTANCE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOPSY; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL NUCLEUS; CISPLATIN; CYTOPLASM; DOXORUBICIN; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FLOW CYTOMETRY; GENISTEIN; HUMANS; LUNG NEOPLASMS; P-GLYCOPROTEIN; VERAPAMIL;

EID: 1842830843     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ota E., Abe Y., Oshika Y. et al. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer 1995; 72: 3: 550-554.
2. Savaraj N., Wu C. J., Xu R. et al. Multidrug-resistant gene expression in small-cell lung cancer. Am J Clin Oncol 1997; 20: 4: 398-403.
3. Oka M., Fukuda M., Sakamoto A. et al. The clinical role of MDR1 gene expression in human lung cancer. Anticancer Res 1997;17: 1B: 721-724.
4. Ettinger D. S. Is there a preferred combination chemotherapy regimen for metastastic non-small cell lung cancer? Oncologist 2002; 7: 3: 226-233.
5. Schiller J. H., Harrington D., Belani C. P. et al Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. New Engl J Med 2002; 346: 2: 92-98.
6. Gonzalez V. M., Fuertes M. A., Alonso C., Perez J. M. Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 2001; 59: 4: 657-663.
7. Russian source
8. Manciu L., Chang X., Riordan J. R. et al. Nucleotide-induced conformational changes in the human multidrug resistance protein MRP1 are related to the capacity of chemotherapeutic drugs to accumulate or not in resistant cells. FEBS Lett 2001; 493: 1: 31-35.
9. Larsen A. K., Escargueil A. E., Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000; 85: 3: 217-229.
10. Gong Y., Wang Y., Chen F. et al. Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line. Leuk Res 2000; 24: 9: 769-774.
11. Chou K. M., Paul Krapcho A., Hacker M. P. Impact of the basic amine on the biological activity and intracellular distribution of an azaanthrapyrazole: BBR 3422. Biochem Pharmacol 2001; 62: 10: 1337-1343.
12. Yang J. Y., Luo H. Y., Lin Q. Y. et al. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R. World J Gastroenterol 2002; 8: 4: 644-649.
13. Campling B. G., Young L. C., Baer K. et al. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Clin. Cancer Res 1997; 3: 1: 115-122-
14. Young L. C., Campling B. G., Cole S. P. et al. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer correlation of protein levels with drug response and messenger RNA levels. Clin Cancer Res 2001; 7: 6: 1798-1804.
15. Canitrot Y., Bichat F., Cole S. P. et al. Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy. Cancer Lett 1998; 130: 1-2: 133-141.
16. Sugawara I., Yamada H., Nakamura H. et al. Preferential expression of the multidrug-resistance-associated protein (MRP) in adenocarcinoma of the lung. Int J Cancer 1995; 64: 5: 322-325.
17. Narasaki F., Matsuo I., Ikuno N. et al. Multidrug resistance-associated protein (MRP) gene expression in human lung cancer. Anticancer Res 1996; 16: 4A: 2079-2082.
18. Ota E., Abe Y., Oshika Y. et al. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer 1995; 72: 3: 550-554.
19. Scheffer G. L., Pijnenborg A. C., Smit E. F. et al. Multidrug resistance related molecules in human and murine lung. J Clin Pathol 2002; 55: 5: 332-339.